J.HabbemaJ

CrossRef Dulaglutide versus empagliflozin as add-on therapy to metformin and sulfonylurea in type 2 diabetes: a randomized pilot study with exploratory metabolomic and microbiome analyses Ji Eun Jun, Da-Hee Oh, In-Kyung Jeong, Hyun Jin Ryu, You-Cheol Hwang, Kyu Jeung Ahn, Ho Yeon Chung, Kwang Pyo Kim Frontiers in Endocrinology.2026;[Epub] CrossRef Prognostic nutritional index and long-term outcomes after coronary artery bypass grafting Haichang Xu, Weiqiang Li, Shen-an-nan Chen, Shuaishuai Zhao, Chengtao Peng, Kang Huang, Xueliang Zhou, Qicai Wu BMC Surgery.2026;[Epub] CrossRef Exploring the risk of depression and suicide/self-injury in patients receiving GLP-1RAs combined with metformin versus GLP-1RA monotherapy: a real-word analysis of the FAERS database Wenjun Ji, Ying Ma, Jie Fang, Linwei Chen Endocrine Connections.2026;[Epub] CrossRef Relationship between insulin resistance surrogate markers with diabetes and dyslipidemia: A Bayesian network analysis of Korean adults Jaeyeop Choi, Jonghyun Kim, Hyun Sook Oh, Marwan Al-Nimer PLOS One.2025

[PMC free article] [PubMed] 222.Chilvery S, Bansod S, Saifi MA, Godugu C
Additionally, C/EBP modulates antioxidative defense mechanisms by regulating NAD(P)H quinone oxidoreductase 1 (NQO1) and glutathione S-transferase pi 1 (GSTP1), protecting GBM cells from oxidative stress